Glaucoma therapy: Prescribing pattern and cost analysis

JK Science

Volumn 6, Issue 2, 2004, Pages 88-92

  Sharma, Rashmi ^a,b   Khajuria, Ruchi ^a   Sharma, Pushpinder ^a   Sadhotra, P ^a   Kapoor, B ^a   Kohli, K ^a   Sharma, C L ^b  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b AMC ^*  (India)

Author keywords

Generic; Glaucoma; Prescribing pattern

Indexed keywords

ACETAZOLAMIDE; ALFADROPS; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; BULOL; CARBONATE DEHYDRATASE INHIBITOR; CARPO MIOTIC; CARTEOLOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; DIPIVEFRINE; DORZOLAMIDE; GENERIC DRUG; IMIDAZOLINE RECEPTOR; IOBET; LATANOPROST; LEVOBUNOLOL; LOCARP; NOPRES; OCUBETA; OCULAN; OCUPRES; OCUTIM; OPTIPRES; OPTIPRES S; PILOCARPINE; PILOMAX; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN F2 ALPHA; TEEMOL; TIMOLEL PLUS; TIMOLEM; TIMOLET GFS; TIMOLO; TIMOLOL; TIMOPRESS;

ACIDOSIS; ARTICLE; BONE MARROW DEPRESSION; CATARACT; COST BENEFIT ANALYSIS; COST CONTROL; DIURESIS; DOSE RESPONSE; DRUG COST; DRUG DOSE REGIMEN; DRUG INSTILLATION; EYE DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; INTERPERSONAL COMMUNICATION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MONOTHERAPY; MYOPIA; NEPHROLITHIASIS; NEUROPROTECTION; NIGHT VISION; OPEN ANGLE GLAUCOMA; PARESTHESIA; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACOECONOMICS; PRESCRIPTION; SIDE EFFECT; SKILL; SUPINE POSITION; TINNITUS; VISUAL ACUITY; VISUAL FIELD;

EID: 3442890910     PISSN: 09721177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kutty GKV, Sambasivam N, Nagarajan M. A study on drug prescribing pattern in maduraicity. Ind J Pharmacol 2002; 34: 361-62.
2. Pradhan SC, Shewade DG, Shashindren CH, Bapna JS. Drug utilization studies. National Med J India 1988; 1: 185-89.
3. Park K. Blindness. In: Park K (ed). Park's Text Book of Preventive and Social medicine. 16th edition. Banarsidas Bhanot Publishers, Jabalpur, India. 2002; 300-03.
4. Sood NN, Sihota R. Primary open angle glaucoma: Etiology and clinical features. In: Dutta LC (ed). Modren Opthalmology, 2nd Edition. Vol 1. Jay Pee Brothers (P). Ltd. India. 2000; 463-68.
5. Schuman SJ, Burke J, Cantor BL, Mattox C. Innovations in the medical management of glaucoma. Oxford institute for continuing Education, 2000.
6. Stephen CG, Mark J, Alan LR, Gail FS. Clinical pharmacology of adrenergic drugs. In: Ritch R, Bruce MS, Theodore K (eds). The Glaucomas. Glaucoma therapy, 2nd Edition. Vol 3. Mosby-Year Book, Inc. 1996; 1425-46.
7. Gautam CS, Bhanwra S, Goel NK, Gupta KS, Sood S. Instillation of drugs in the eye. Importance of proper instructions to the patients. Ind J Pharmacol 2001; 33: 386.
8. Malik S. Antiglaucoma drugs. Indian Drug Review, a mediworld publication. 2003; 123-25.
9. Mastropasqua L, Ciancaglini M, Carpineto P, Zuppardi E, Falconio G and Gallenga PE. Effects of Brimonidine 0.2% on blue-yellow perimetery of glaucomatous patients. Acta Ophthalmologica Scandinavica 1998; 76: 36.
10. Yuksel N, Altintas O, Karabus L, Alp B and Caglar Y. The short effect of adding Brimonidine 0.2% to Timolol treatment in patients with open angle glaucoma. Ophthamologica 1999; 213: 228-33.
11. Rolle T, Cipullo D, Vizzeri GM, Triggiani A and Brogliatti B. Evaluation and comparison between the effects on IOP and retinal blood flow of two anti glaucomatous drugs administered in monotherapy: Brimonidine and Latanoprost. Preliminary results. Acta Ophthalmologica Scandinavica 2000; 78: 50-52.
12. Carlsson MA, Chauhan CB, Lee AA and Leblanc PR. The effects of Brimonidine tartrate on retinal blood flow in patients with ocular hypertention. Am J Ophthamol 2000: 129: 297-301.
13. Dutta LC, Maskati BT, Dutta KK. Current trends in drug therapy of POAG. In: Dutta LC (ed). Modern Ophthalmology, 2nd edition, vol. 1 Jay Pee Brothers (P) Ltd., India. 2000: 481-87.
14. Strahlman E, Tipping R, Vogel R et al. Double masked, randomized one year study comparing dorzolamide (Trusopt), timolol and betaxolol. Arch Ophthalmol 1995; 113: 1009-16.
15. Palmeberg P and Fla M. A topical carbonic-anhydrase inhibitor finally arrives. Arch Ophthalmol 1995; 113: 985-86.
16. Biswas NR, Jindal S, Siddiquei MM. Pattern of prescription and drug use in Ophthalmology in a tertiary hospital in Delhi. Br J Clin Pharmacol 2001; 51: 267-69.
17. Fiscella GR, Green A, Patuszynski HD, Jacob W. Medical therapy cost consideration for glaucoma. Am J Ophthalmol 2003; 1369: 18-25.